Anti-Monomeric C-Reactive Protein Antibody Ameliorates Arthritis and Nephritis in Mice

Conformation-specific Ags are ideal targets for mAb-based immunotherapy. Here, we demonstrate that the monomeric form of C-reactive protein (mCRP) is a specific therapeutic target for arthritis and nephritis in a murine model. Screening of >1800 anti-mCRP mAb clones identified 3C as a clone recog...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 207; no. 7; pp. 1755 - 1762
Main Authors Fujita, Chitose, Sakurai, Yasuo, Yasuda, Yuki, Takada, Yoshikazu, Huang, Cheng-Long, Fujita, Masaaki
Format Journal Article
LanguageEnglish
Published 01.10.2021
Online AccessGet full text

Cover

Abstract Conformation-specific Ags are ideal targets for mAb-based immunotherapy. Here, we demonstrate that the monomeric form of C-reactive protein (mCRP) is a specific therapeutic target for arthritis and nephritis in a murine model. Screening of >1800 anti-mCRP mAb clones identified 3C as a clone recognizing the monomeric, but not polymeric, form of CRP. The anti-mCRP mAb suppressed leukocyte infiltration in thioglycollate-induced peritonitis, attenuated rheumatoid arthritis symptoms in collagen Ab-induced arthritis model mice, and attenuated lupus nephritis symptoms in MRL/Mp-lpr/lpr lupus-prone model mice. These data suggest that the anti-mCRP mAb 3C has therapeutic potential against rheumatoid arthritis and lupus nephritis.
AbstractList Conformation-specific Ags are ideal targets for mAb-based immunotherapy. Here, we demonstrate that the monomeric form of C-reactive protein (mCRP) is a specific therapeutic target for arthritis and nephritis in a murine model. Screening of >1800 anti-mCRP mAb clones identified 3C as a clone recognizing the monomeric, but not polymeric, form of CRP. The anti-mCRP mAb suppressed leukocyte infiltration in thioglycollate-induced peritonitis, attenuated rheumatoid arthritis symptoms in collagen Ab-induced arthritis model mice, and attenuated lupus nephritis symptoms in MRL/Mp-lpr/lpr lupus-prone model mice. These data suggest that the anti-mCRP mAb 3C has therapeutic potential against rheumatoid arthritis and lupus nephritis.Conformation-specific Ags are ideal targets for mAb-based immunotherapy. Here, we demonstrate that the monomeric form of C-reactive protein (mCRP) is a specific therapeutic target for arthritis and nephritis in a murine model. Screening of >1800 anti-mCRP mAb clones identified 3C as a clone recognizing the monomeric, but not polymeric, form of CRP. The anti-mCRP mAb suppressed leukocyte infiltration in thioglycollate-induced peritonitis, attenuated rheumatoid arthritis symptoms in collagen Ab-induced arthritis model mice, and attenuated lupus nephritis symptoms in MRL/Mp-lpr/lpr lupus-prone model mice. These data suggest that the anti-mCRP mAb 3C has therapeutic potential against rheumatoid arthritis and lupus nephritis.
Conformation-specific Ags are ideal targets for mAb-based immunotherapy. Here, we demonstrate that the monomeric form of C-reactive protein (mCRP) is a specific therapeutic target for arthritis and nephritis in a murine model. Screening of >1800 anti-mCRP mAb clones identified 3C as a clone recognizing the monomeric, but not polymeric, form of CRP. The anti-mCRP mAb suppressed leukocyte infiltration in thioglycollate-induced peritonitis, attenuated rheumatoid arthritis symptoms in collagen Ab-induced arthritis model mice, and attenuated lupus nephritis symptoms in MRL/Mp-lpr/lpr lupus-prone model mice. These data suggest that the anti-mCRP mAb 3C has therapeutic potential against rheumatoid arthritis and lupus nephritis.
Author Fujita, Masaaki
Huang, Cheng-Long
Fujita, Chitose
Takada, Yoshikazu
Sakurai, Yasuo
Yasuda, Yuki
Author_xml – sequence: 1
  givenname: Chitose
  surname: Fujita
  fullname: Fujita, Chitose
– sequence: 2
  givenname: Yasuo
  surname: Sakurai
  fullname: Sakurai, Yasuo
– sequence: 3
  givenname: Yuki
  orcidid: 0000-0003-1259-6908
  surname: Yasuda
  fullname: Yasuda, Yuki
– sequence: 4
  givenname: Yoshikazu
  surname: Takada
  fullname: Takada, Yoshikazu
– sequence: 5
  givenname: Cheng-Long
  surname: Huang
  fullname: Huang, Cheng-Long
– sequence: 6
  givenname: Masaaki
  surname: Fujita
  fullname: Fujita, Masaaki
BookMark eNp1kEFLwzAUgINMcJvePfbopfMlTdPlWIY6YVMR9VrS1xQz2mQmmbB_b8fmRfDyHg--7x2-CRlZZzUh1xRmHLi83Zi-31nXzRgFyLg8I2Oa55AKAWJExgCMpbQQxQWZhLABAAGMj8lHaaNJ1866XnuDySJ91Qqj-dbJi3dRG5sciNo1-6TsdWecV1GHpPTx05toQqJskzzp7eka-LVBfUnOW9UFfXXaU_J-f_e2WKar54fHRblKMeMspnnOGFAsgEpaF7RROC_aYWRzpHXbCsYQRYZQt8gVVUxALqXkTcOErAXFbEpujn-33n3tdIhVbwLqrlNWu12oWC7muQTKiwEVRxS9C8HrtkITVTTORq9MV1GoDiGr35DVKeQgwh9x602v_P5_5QfRPHtA
CitedBy_id crossref_primary_10_1016_j_pharmthera_2022_108165
crossref_primary_10_1302_2046_3758_123_BJR_2022_0223_R1
crossref_primary_10_3389_fimmu_2022_866379
crossref_primary_10_2139_ssrn_4020158
crossref_primary_10_3389_fimmu_2022_938173
crossref_primary_10_1016_j_clim_2024_110353
crossref_primary_10_3389_fimmu_2024_1385085
crossref_primary_10_3389_fimmu_2025_1564607
crossref_primary_10_3389_fimmu_2023_1264383
crossref_primary_10_4049_jimmunol_2200831
crossref_primary_10_3390_ijms24032079
crossref_primary_10_3390_diseases11040132
crossref_primary_10_2147_JIR_S490958
Cites_doi 10.1021/cr200085w
10.1042/bj20020045
10.3389/fimmu.2020.00115
10.1016/0161-5890(83)90140-2
10.1016/j.atherosclerosis.2015.01.024
10.1056/NEJMoa1315878
10.1074/jbc.M114.579946
10.1084/jem.148.5.1198
10.3389/fimmu.2018.01089
10.1161/ATVBAHA.108.174359
10.1056/NEJM199902113400607
10.1111/j.1750-3639.2008.00256.x
10.1038/nature04672
10.1161/01.CIR.0000146846.00816.DD
10.1038/srep13281
10.1038/nrd4381
10.1093/cvr/cvs237
10.1155/2015/372432
10.4049/jimmunol.143.1.221
10.4049/jimmunol.170.6.3223
10.4161/cc.8.23.10068
10.1084/jem.152.5.1302
10.1074/jbc.M115.695023
10.1074/jbc.M307764200
10.1161/01.CIR.0000125527.41598.68
10.1096/fj.08-116962
10.1016/j.jim.2019.04.009
10.4049/jimmunol.1900043
10.1016/j.jim.2009.01.009
10.1038/ncomms14188
10.1021/bi9827619
10.1074/jbc.M205378200
10.1016/j.biocel.2004.07.002
10.1371/journal.pone.0093738
10.1002/eji.1830180221
10.1186/ar3339
10.1046/j.1523-1755.1999.055003864.x
10.1074/jbc.R400025200
10.3389/fimmu.2020.02126
ContentType Journal Article
Copyright Copyright © 2021 by The American Association of Immunologists, Inc.
Copyright_xml – notice: Copyright © 2021 by The American Association of Immunologists, Inc.
DBID AAYXX
CITATION
7X8
DOI 10.4049/jimmunol.2100349
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 1762
ExternalDocumentID 10_4049_jimmunol_2100349
GroupedDBID ---
-~X
.55
0R~
18M
2WC
34G
39C
53G
5GY
5RE
5VS
5WD
79B
85S
AARDX
AAYXX
ABCQX
ABDFA
ABEJV
ABGNP
ABJNI
ABOCM
ABPPZ
ABXVV
ACGFO
ACGFS
ACIWK
ACNCT
ACPRK
ADBBV
ADIPN
ADNWM
AENEX
AETEA
AFHIN
AFOSN
AFRAH
AGORE
AHMMS
AHWXS
AIZAD
ALMA_UNASSIGNED_HOLDINGS
ARBBW
BAWUL
BCRHZ
BTFSW
CITATION
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
IH2
K-O
KOP
KQ8
L7B
OCZFY
OK1
OWPYF
P0W
P2P
PQQKQ
R.V
RHI
ROX
RZQ
SJN
TR2
TWZ
W8F
WH7
WOQ
X7M
XSW
XTH
YHG
7X8
ID FETCH-LOGICAL-c342t-552201c70191b71dac87fac838c1bff622cc63c0bfc4a1a26059994dd269b61c3
ISSN 0022-1767
1550-6606
IngestDate Thu Jul 10 18:38:10 EDT 2025
Tue Jul 01 05:22:53 EDT 2025
Thu Apr 24 22:58:23 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License https://academic.oup.com/pages/standard-publication-reuse-rights
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c342t-552201c70191b71dac87fac838c1bff622cc63c0bfc4a1a26059994dd269b61c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-1259-6908
PQID 2568590147
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2568590147
crossref_citationtrail_10_4049_jimmunol_2100349
crossref_primary_10_4049_jimmunol_2100349
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-10-01
20211001
PublicationDateYYYYMMDD 2021-10-01
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-01
  day: 01
PublicationDecade 2020
PublicationTitle The Journal of immunology (1950)
PublicationYear 2021
References Khreiss (2025022610321447700_r8) 2002; 277
Potempa (2025022610321447700_r29) 1983; 20
Black (2025022610321447700_r10) 2004; 279
Misaki (2025022610321447700_r30) 2011; 13
Ji (2025022610321447700_r13) 2009; 23
Gaboriaud (2025022610321447700_r19) 2003; 278
Ying (2025022610321447700_r28) 1989; 143
Khreiss (2025022610321447700_r11) 2004; 110
Slevin (2025022610321447700_r18) 2010; 20
Molins (2025022610321447700_r27) 2008; 28
Khreiss (2025022610321447700_r12) 2004; 109
Fujita (2025022610321447700_r33) 2015; 290
Williams (2025022610321447700_r6) 2020; 11
Potter (2025022610321447700_r34) 2003; 170
Eisenhardt (2025022610321447700_r2) 2009; 8
Yao (2025022610321447700_r5) 2019; 470
Thiele (2025022610321447700_r4) 2015; 2015
Wang (2025022610321447700_r17) 2015; 239
Pepys (2025022610321447700_r25) 2006; 440
Mullard (2025022610321447700_r24) 2014; 13
Braig (2025022610321447700_r7) 2017; 8
Andrews (2025022610321447700_r36) 1978; 148
Yokoyama (2025022610321447700_r32) 1999; 38
Pisetsky (2025022610321447700_r38) 1980; 152
Li (2025022610321447700_r14) 2016; 291
Heuertz (2025022610321447700_r26) 2005; 37
Kamata (2025022610321447700_r31) 1999; 55
Gabay (2025022610321447700_r1) 1999; 340
Dennis (2025022610321447700_r22) 2011; 111
Caprio (2025022610321447700_r9) 2018; 9
Fujita (2025022610321447700_r16) 2014; 9
Slevin (2025022610321447700_r20) 2015; 5
Habersberger (2025022610321447700_r21) 2012; 96
Perper (2025022610321447700_r37) 2019; 203
White (2025022610321447700_r23) 2014; 370
Fu (2025022610321447700_r15) 2002; 366
Rajab (2025022610321447700_r3) 2020; 11
Hutamekalin (2025022610321447700_r35) 2009; 343
Vieira (2025022610321447700_r39) 1988; 18
References_xml – volume: 111
  start-page: 6130
  year: 2011
  ident: 2025022610321447700_r22
  article-title: Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention
  publication-title: Chem. Rev.
  doi: 10.1021/cr200085w
– volume: 366
  start-page: 195
  year: 2002
  ident: 2025022610321447700_r15
  article-title: Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions
  publication-title: Biochem. J.
  doi: 10.1042/bj20020045
– volume: 11
  start-page: 115
  year: 2020
  ident: 2025022610321447700_r6
  article-title: Monomeric C-reactive protein in serum with markedly elevated CRP levels shares common calcium-dependent ligand binding properties with an in vitro dissociated form of C-reactive protein
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.00115
– volume: 20
  start-page: 1165
  year: 1983
  ident: 2025022610321447700_r29
  article-title: Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium
  publication-title: Mol. Immunol.
  doi: 10.1016/0161-5890(83)90140-2
– volume: 239
  start-page: 343
  year: 2015
  ident: 2025022610321447700_r17
  article-title: Increased monomeric CRP levels in acute myocardial infarction: a possible new and specific biomarker for diagnosis and severity assessment of disease
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2015.01.024
– volume: 370
  start-page: 1702
  year: 2014
  ident: 2025022610321447700_r23
  article-title: Darapladib for preventing ischemic events in stable coronary heart disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1315878
– volume: 290
  start-page: 259
  year: 2015
  ident: 2025022610321447700_r33
  article-title: Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M114.579946
– volume: 148
  start-page: 1198
  year: 1978
  ident: 2025022610321447700_r36
  article-title: Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.148.5.1198
– volume: 9
  start-page: 1089
  year: 2018
  ident: 2025022610321447700_r9
  article-title: pCRP-mCRP Dissociation mechanisms as potential targets for the development of small-molecule anti-Inflammatory chemotherapeutics
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.01089
– volume: 28
  start-page: 2239
  year: 2008
  ident: 2025022610321447700_r27
  article-title: C-reactive protein isoforms differ in their effects on thrombus growth
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.108.174359
– volume: 340
  start-page: 448
  year: 1999
  ident: 2025022610321447700_r1
  article-title: Acute-phase proteins and other systemic responses to inflammation
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199902113400607
– volume: 20
  start-page: 151
  year: 2010
  ident: 2025022610321447700_r18
  article-title: Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro
  publication-title: Brain Pathol.
  doi: 10.1111/j.1750-3639.2008.00256.x
– volume: 440
  start-page: 1217
  year: 2006
  ident: 2025022610321447700_r25
  article-title: Targeting C-reactive protein for the treatment of cardiovascular disease
  publication-title: Nature
  doi: 10.1038/nature04672
– volume: 110
  start-page: 2713
  year: 2004
  ident: 2025022610321447700_r11
  article-title: Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000146846.00816.DD
– volume: 5
  start-page: 13281
  year: 2015
  ident: 2025022610321447700_r20
  article-title: Monomeric C-reactive protein--a key molecule driving development of Alzheimer’s disease associated with brain ischaemia?
  publication-title: Sci. Rep.
  doi: 10.1038/srep13281
– volume: 13
  start-page: 481
  year: 2014
  ident: 2025022610321447700_r24
  article-title: GSK’s darapladib failures dim hopes for anti-inflammatory heart drugs
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd4381
– volume: 96
  start-page: 64
  year: 2012
  ident: 2025022610321447700_r21
  article-title: Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvs237
– volume: 2015
  start-page: 372432
  year: 2015
  ident: 2025022610321447700_r4
  article-title: Targeting C-reactive protein in inflammatory disease by preventing conformational changes
  publication-title: Mediators Inflamm.
  doi: 10.1155/2015/372432
– volume: 143
  start-page: 221
  year: 1989
  ident: 2025022610321447700_r28
  article-title: Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.143.1.221
– volume: 170
  start-page: 3223
  year: 2003
  ident: 2025022610321447700_r34
  article-title: Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.170.6.3223
– volume: 8
  start-page: 3885
  year: 2009
  ident: 2025022610321447700_r2
  article-title: C-reactive protein: how conformational changes influence inflammatory properties
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.23.10068
– volume: 152
  start-page: 1302
  year: 1980
  ident: 2025022610321447700_r38
  article-title: Mechanisms of autoantibody production in autoimmune MRL mice
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.152.5.1302
– volume: 291
  start-page: 8795
  year: 2016
  ident: 2025022610321447700_r14
  article-title: An Intrinsically disordered motif mediates diverse actions of monomeric C-reactive protein
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M115.695023
– volume: 278
  start-page: 46974
  year: 2003
  ident: 2025022610321447700_r19
  article-title: The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M307764200
– volume: 109
  start-page: 2016
  year: 2004
  ident: 2025022610321447700_r12
  article-title: Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000125527.41598.68
– volume: 23
  start-page: 1806
  year: 2009
  ident: 2025022610321447700_r13
  article-title: Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains
  publication-title: FASEB J.
  doi: 10.1096/fj.08-116962
– volume: 470
  start-page: 40
  year: 2019
  ident: 2025022610321447700_r5
  article-title: A redox sensitivity-based method to quantify both pentameric and monomeric C-reactive protein in a single assay
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2019.04.009
– volume: 203
  start-page: 58
  year: 2019
  ident: 2025022610321447700_r37
  article-title: Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1900043
– volume: 343
  start-page: 49
  year: 2009
  ident: 2025022610321447700_r35
  article-title: Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2009.01.009
– volume: 8
  start-page: 14188
  year: 2017
  ident: 2025022610321447700_r7
  article-title: Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms14188
– volume: 38
  start-page: 5872
  year: 1999
  ident: 2025022610321447700_r32
  article-title: Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains
  publication-title: Biochemistry
  doi: 10.1021/bi9827619
– volume: 277
  start-page: 40775
  year: 2002
  ident: 2025022610321447700_r8
  article-title: Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M205378200
– volume: 37
  start-page: 320
  year: 2005
  ident: 2025022610321447700_r26
  article-title: Native and modified C-reactive protein bind different receptors on human neutrophils
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2004.07.002
– volume: 9
  start-page: e93738
  year: 2014
  ident: 2025022610321447700_r16
  article-title: The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0093738
– volume: 18
  start-page: 313
  year: 1988
  ident: 2025022610321447700_r39
  article-title: The half-lives of serum immunoglobulins in adult mice
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.1830180221
– volume: 13
  start-page: R77
  year: 2011
  ident: 2025022610321447700_r30
  article-title: Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice
  publication-title: Arthritis Res. Ther.
  doi: 10.1186/ar3339
– volume: 55
  start-page: 864
  year: 1999
  ident: 2025022610321447700_r31
  article-title: Up-regulation of glomerular extracellular matrix and transforming growth factor-beta expression in RF/J mice
  publication-title: Kidney Int.
  doi: 10.1046/j.1523-1755.1999.055003864.x
– volume: 279
  start-page: 48487
  year: 2004
  ident: 2025022610321447700_r10
  article-title: C-reactive Protein
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.R400025200
– volume: 11
  start-page: 2126
  year: 2020
  ident: 2025022610321447700_r3
  article-title: How C-reactive protein structural isoforms with distinctive bioactivities affect disease progression
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.02126
SSID ssj0006024
Score 2.4545252
Snippet Conformation-specific Ags are ideal targets for mAb-based immunotherapy. Here, we demonstrate that the monomeric form of C-reactive protein (mCRP) is a...
SourceID proquest
crossref
SourceType Aggregation Database
Enrichment Source
Index Database
StartPage 1755
Title Anti-Monomeric C-Reactive Protein Antibody Ameliorates Arthritis and Nephritis in Mice
URI https://www.proquest.com/docview/2568590147
Volume 207
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfKEIjLBAPEGCAjwYFDuthxnHCsKqYB6g6woe0U2Y6jZp2aqU0O21_Cn8t7ifPRChDjYjWW85T6_fT8nt8XIe8ipqW2PPVikUpPZMALWBl5IjI2NDz2TYz5zrMTeXwmvpyH56PRz0HUUlXqsbn9bV7J_3AV5oCvmCV7B852RGECfgN_YQQOw_hPPJ4sy9ybYVpCHRA_9b5ZVcsvjP_HNpZYGyDXRXqDnpkrzMbHa9bJqpzXtYxqz8GJvXZPsH7mQuFafbXPHGuKS2A2SVO16X3tG_MHNwlH1WXe6KLTOciJ3uvzXS2qVdP2-kKtq6KTNPCQ1i9cVIu8v0NYKDdbrOf5Qt1Ww6sJzrogt2GqAIuafhtj6yRsCPaq9OVQBPOm863DWjQQqKDdhIPDmTnZvS34BRg6KPjdNozBkMXCO_0h1zr2t86-LiIRbCGkkbQUEkfhHrnPwQCpjfXPX7szXvpctHXo8Q82DnCkcLj9DZsKz-Z5Xysxp4_JruMknTRQekJGdrlHHjT9SG_2yMOZi7R4Sn5sYov22KIOW7TFFh1gi3bYooAt2mGLwnrE1jNydvTpdHrsuR4cngkEL70Q9HOfGSzaz3TEUmXiKIMhiA3TWSY5N0YGxteZEYoptI7B5BBpyuVHLZkJnpOdZbG0LwjNuPGzVPiaB4HIONMhFynIBW1DIWKm9slhu1GJcQXqsU_KVfIn5uyTD90b101xlr-sfdvufQISFN1iammLap2A0h9jBraIXt6B3gF51EP-FdkpV5V9Dfppqd_UUPkFcU6TNg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-Monomeric+C-Reactive+Protein+Antibody+Ameliorates+Arthritis+and+Nephritis+in+Mice&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Fujita%2C+Chitose&rft.au=Sakurai%2C+Yasuo&rft.au=Yasuda%2C+Yuki&rft.au=Takada%2C+Yoshikazu&rft.date=2021-10-01&rft.issn=0022-1767&rft.eissn=1550-6606&rft.volume=207&rft.issue=7&rft.spage=1755&rft.epage=1762&rft_id=info:doi/10.4049%2Fjimmunol.2100349&rft.externalDBID=n%2Fa&rft.externalDocID=10_4049_jimmunol_2100349
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon